Read #MEAction’s Request for Information response to the NIH

Share on facebook
Share on twitter
Share on email

The story so far

NINDS, the National Institute for Neurological Disorder and Stroke at the NIH has solicited an RFI, or a Request for Information, from the ME community on how to advance research for myalgic encephalomyelitis.  

With only a few weeks’ turn-around, the #MEAction NIH working group produced a compelling response based on information conveyed in dozens of patient-led efforts over ME advocacy’s history.

Then, we posted our drafted response and solicited input from the community at large.


What now?

The #MEAction NIH Working Group worked swiftly to incorporate this community feedback into our draft and sent the finalized RFI response to the NIH under the deadline.  You can read that finalized version here:

 

 


What’s next?

NANDS (National Advisory Neurological Disorders and Stroke) will read the RFI responses. There will be many more meetings, both whole group and subgroups. Each subgroup will analyze the RFI input and refine the report recommendations accordingly. A finalized report will go to NANDS in early September and this will be used to inform recommendations to advance ME research at NINDS.

We’ve waited a year to hear their plan for ME. We expect to hear that it will be sensible, robust, and have concrete endpoints and goals in order to determine success.

Our job is to continue to push for our community’s hard work so far to bear fruit. Search for NIH, NANDS, and NINDS tags on #MEAction for updates and further news on this front.

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe